Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05398341 · ClinicalTrials.gov registry record

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

A clinical trial of Anterior Cruciate Ligament Injuries, sponsored by Miach Orthopaedics.

Active
Registry status
300
Enrollment target
9
Study locations

NCT05398341 is a study of Anterior Cruciate Ligament Injuries that is active but no longer recruiting, run by Miach Orthopaedics. The registered enrollment target is 300 participants, roughly in line with the 311-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target. The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05398341, a study of Anterior Cruciate Ligament Injuries, is active but no longer recruiting, sponsored by Miach Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
9
Study locations

Study Summary

The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.

Interventions

  • DEVICE The BEAR® Implant

Study Locations (9)

New York

  • Hospital for Special Surgery - New York
  • Victory Sports Medicine - Skaneateles

California

  • Stanford - Redwood City

Colorado

  • Steamboat Orthopaedic and Spine Institute - Steamboat Springs

Florida

  • Advent Health - Orlando

Massachusetts

  • Boston Children's Hospital - Boston

New Jersey

  • Virtua Health - Marlton

North Carolina

  • Duke University - Durham

Oregon

  • Oregon Health & Science University (OHSU) - Portland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-02-28
Est. Completion 2027-01-30

Sponsor

Miach Orthopaedics

4 total trials

What the Registry Record Tells You About NCT05398341

The ClinicalTrials.gov registry entry for NCT05398341 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 311-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target. The listed sponsor is Miach Orthopaedics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which The BEAR® Implant is the first listed.

NCT05398341 reports 9 study locations spanning 8 distinct geographic areas - top geographies include New York, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT05398341 about?

NCT05398341 is a clinical study titled "A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)". The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.

What is the current status of trial NCT05398341?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2023-02-28. Estimated completion is 2027-01-30.

What conditions does trial NCT05398341 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries.

What interventions are being tested in trial NCT05398341?

The interventions under investigation include: The BEAR® Implant (DEVICE).

Who is sponsoring clinical trial NCT05398341?

This trial is sponsored by Miach Orthopaedics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05398341 being conducted?

This trial has 9 study locations across California, Colorado, Florida, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.